Quantcast

Latest General anesthetics Stories

2011-09-21 13:05:22

MGH study demonstrates what may be first feasible method to induce arousal from anesthesia Administration of the commonly used stimulant drug methylphenidate (Ritalin) was able to speed recovery from general anesthesia in an animal study conducted at Massachusetts General Hospital (MGH). The report, appearing in the October issue of Anesthesiology, is the first demonstration in mammals of what could be a safe and effective way to induce arousal from general anesthesia. While there are...

2011-08-05 17:04:00

LAS VEGAS, Aug. 5, 2011 /PRNewswire/ -- Jury selection in the second trial in the largest hepatitis C outbreak in U.S. history has begun in Clark County, Nevada. The Nevada Supreme Court lifted the stay allowing the case to go to trial when it was determined by the court that nurse David Hambrick, a witness for the defense Teva Inc. and Baxter Inc., "does not possess the requisite skill, knowledge or experience to testify as an expert witness regarding the medical cause of hepatitis C...

2011-07-28 15:15:00

CUPERTINO, Calif., July 28, 2011 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2011 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, August 4, 2011 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2011-07-07 14:48:00

CHICAGO, July 6, 2011 /PRNewswire/ -- On June 30, 2011, just three weeks after hearing oral argument, the First District of the Illinois Court of Appeals affirmed a $16.56 million judgment against Johnson & Johnson (NYSE: JNJ) subsidiaries Janssen Pharmaceutica Inc. and ALZA Corporation in a wrongful death case involving their Duragesic® fentanyl pain patch. The court's opinion completely affirmed the November 2008 judgment in DiCosolo v. ALZA Corp, et al., obtained...

2011-06-03 07:30:00

CUPERTINO, Calif., June 3, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Jim Brown, President and CEO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June 7 at 4:30 p.m. Eastern time. The conference is being held at the Grand Hyatt in New York. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at www.durect.com and clicking "Investor...

2011-06-02 15:15:00

CUPERTINO, Calif., June 2, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Dr. Joseph Stauffer, Chief Medical Officer and Executive Vice President, Corporate Strategy has resigned effective June 21, 2011 to pursue other opportunities. Dr. Stauffer and DURECT have entered into a consulting agreement through December 31, 2011. (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) "We appreciate all of Joe's efforts over the last two years, most notably in...

2011-05-31 06:30:00

REDWOOD CITY, Calif., May 31, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)(AcelRx), today announced that the US Army Medical Research and Material Command (USAMRMC) has awarded AcelRx a $5.6 million grant to support the development of a new product candidate, ARX-04, a proprietary non-invasive, fast-onset sublingual product for the treatment of moderate-to-severe acute pain. Commenting on the award, Richard King, AcelRx President and Chief Executive Officer stated,...

2011-05-18 10:37:00

REDWOOD CITY, Calif., May 18, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today that the results from its Phase 2 clinical studies related to two product candidates, ARX-01 Sufentanil NanoTab(R) PCA System, which is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia and ARX-03 to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office, will be featured in...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.